ABUS: Arbutus Biopharma Corporation
Performance
ABUS -17.33%
Watchlist
Select an item
Summary
ABUS at a glance
ABUS returned -17.33% over the past year and +1.34% a year over five years. Its worst drop in that year was -29.98%, smaller than 58% of stocks on Redstone, and its Sharpe ratio of -0.26 beats 17% of stocks on Redstone. It pays no dividends.
Current Drawdown
-28.74%
Rolling Volatility
47.40%
Actions
Metrics
Risk Indicators
Alpha-24.39%
Beta1.25x
Sharpe-0.26
Sortino-0.36
Omega0.96
Calmar-0.58
Martin-0.98
Profile
About ABUS
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $737M
- Listed
- Jul 2007
- Employees
- 19
- Headquarters
- Warminster, PA
- Website
- arbutusbio.com
Comparisons